Researchers developed an alloyed Ir- and Ru-based oxide with enhanced atomic steps, improving its electrocatalytic performance. The novel nanomaterial outperformed commercially available iridium dioxide in hydrogen production, offering a cleaner and more affordable alternative.
SourceTsinghua University Press·JournalNano Research·DateApr 9, 2022
Recent progress in targeted nanomedicine for managing resistance and toxicity of cisplatin in cancer therapy is reviewed. The article highlights strategies to increase cisplatin sensitivity through improved intracellular concentration and combination therapy, as well as novel approaches targeting tumor microenvironment and immunotherapy.
SourceInnovation Center of NanoMedicine·JournalJournal of Controlled Release·TypeLiterature review·DateApr 9, 2022